Update: Immunotherapeutic Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma
The incidence of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) has increased substantially over the past three decades, and since 2017, it has been recognized in the AJCC staging system as distinct from its HPV-negative counterpart. The underlying mechanisms of...
Saved in:
| Main Authors: | Fangdi Sun, A. Dimitrios Colevas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/17/5/712 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of divergent gene expression between HPV + and HPV- head and neck squamous cell carcinoma patients
by: Kasturika Shankar, et al.
Published: (2025-05-01) -
HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours
by: Jason K. Wasserman, et al.
Published: (2017-01-01) -
The Role of Monoclonal Antibodies as Therapeutics in HPV-Related Head and Neck Cancers: An Updated Review
by: Michael Zalin, et al.
Published: (2025-04-01) -
Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human disease
by: Franziska Oliveri, et al.
Published: (2025-01-01) -
Medical students’ knowledge about human papillomavirus (HPV), HPV vaccine and head and neck cancer
by: Norangelys Solis-Torres, et al.
Published: (2024-12-01)